Paylocity Announces Ellen Carnahan Joining Board of Directors
Nov 09, 2016 21:05 pm UTC| Business
ARLINGTON HEIGHTS, Ill., Nov. 09, 2016 -- Paylocity (Nasdaq:PCTY), a leading provider of cloud based payroll and human capital management software, today announced Ellen Carnahan has joined the company's Board of...
Chiasma Provides Corporate Update and Reports Third Quarter 2016 Results
Nov 09, 2016 21:05 pm UTC| Business
WALTHAM, Mass., Nov. 09, 2016 -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today provided a corporate update and reported...
Adaptimmune Announces Removal of Partial Clinical Hold in Myxoid/Round Cell Liposarcoma (MRCLS)
Nov 09, 2016 21:05 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Nov. 09, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has removed...
Everi Reports 2016 Third Quarter Results
Nov 09, 2016 21:05 pm UTC| Business
LAS VEGAS, Nov. 09, 2016 -- Everi Holdings Inc. (NYSE:EVRI) (“Everi” or the “Company”) today reported financial results for the third quarter ended September 30, 2016. Consolidated Full Quarter Comparative Results...
Stewardship Financial Corporation Reports Earnings for Third Quarter of 2016
Nov 09, 2016 21:05 pm UTC| Business
MIDLAND PARK, N.J., Nov. 09, 2016 -- Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, reported net income available to common shareholders for the three and nine months ended...
Nov 09, 2016 21:05 pm UTC| Business
BOSTON, Nov. 09, 2016 -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of security data and analytics solutions, today announced its financial results for the third quarter of 2016. “Our third quarter results showed...
Nov 09, 2016 21:05 pm UTC| Business
All dose levels of PRX002 found to have an acceptable safety and tolerability profile, meeting the primary objective of this studyRobust central nervous system (CNS) penetration demonstrated by a dose-dependent increase in...